Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons

Neuroepidemiology

Volumn 26, Issue 1, 2005, Pages 30-36

  Shah, Raj C ^a,c   Wilson, Robert S ^a,c   Bienias, Julia L ^b,c   Arvanitakis, Zoe ^a,c   Evans, Denis A ^b,c   Bennett, David A ^a,c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Antihypertensive agents; Apolipoprotein E; Blood pressure; Cognition; Longitudinal studies

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CLERGY; CLINICAL EXAMINATION; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; EDUCATION; FEMALE; GENOTYPE; HAZARD; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; RISK; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

AGED; ALZHEIMER DISEASE; ANTIHYPERTENSIVE AGENTS; APOLIPOPROTEINS E; BLOOD PRESSURE; CLERGY; COGNITION; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 29144487953     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089235     Document Type: Article

References (49)

1. Kivipelto M, Helkala E-L, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissien A: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-1451.
2. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ: Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000;21:49-55.
3. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ: Low blood pressure and the risk of dementia in very old individuals. Neurology 2003;61:1667-1672.
4. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, Persson G, Oden A, Svanborg A: 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
5. Guo Z, Viitanen M, Winblad B, Fratiglioni L: Low blood pressure and incidence of dementia in a very old sample: dependent on initial cognition. J Am Geriatr Soc 1999;47:723-726.
6. Posner HB, Tang M-X, Luchsinger J, Lantigua R, Stern Y, Mayeux R: The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002;58:1175-1181.
7. Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA: Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 2001;58:1640-1646.
8. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, Kobalava Z, Sarti C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Birkenhager WH: The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med 2002;162:2046-2052.
9. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Filenbaum G, Heyman A: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V: A normative study of the neuropsychological battery. Neurology 1994;44:609-614.
10. McKhann G, Drachman D, Holstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
11. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
12. Weschler D: Wechsler Memory Scale: Revised Manual. San Antonio, Psychological Corp, 1987.
13. Albert M, Smith L, Scherr P, Taylor JO, Evans DA, Funkenstein HH: Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-178.
14. Kaplan EF, Goodglass H, Weintraub S: The Boston Naming Test. Philadelphia, Lea & Febiger, 1983.
15. Ekstrom RB, French FW, Harman HH, Kerman D: Manual for kit of factor-referenced cognitive tests. Princeton, Educational Testing Service, 1976.
16. Nelson HE: National Adult Reading Test (NART) Manual. Windsor, NFER-Nelson, 1982.
17. Cooper JA, Sager HJ: Incidental and intentional recall in Parkinson's disease: an account based on diminished attentional resources. J Clin Exp Neuropsychol 1993;15:713-731.
18. Craik FIM: A functional account of age differences in memory: in Klix E, Hagendorf H (eds): Human Memory and Cognitive Capabilities: Mechanisms and Performances. Amsterdam, Elsevier Science Publishers BV, 1986, pp 409-422.
19. Smith A: Symbol Digit Modalities Test Manual, revised. Los Angeles, Western Psychological Services, 1982.
20. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O: Contributions to Neuropsychological Assessment, ed 2. New York, Oxford University Press, 1994.
21. Raven JC, Court JH, Raven J: Manual for Raven's Progressive Matrices and Vocabulary: Standard Progressive Matrices. Oxford, Oxford Psychologists Press, 1992.
22. SAS Institute Inc: SAS/STAT® User's Guide, version 8. Cary, SAS Institute,2000.
23. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, Bach J: Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
24. Wilson RS, Beckett LA, Barnes LL, Schneider JA, Bach J, Evans DA, Bennett DA: Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179-193.
25. Wilson RS, Bienias JL, Berry-Kravis E, Evans DA, Bennett DA: The apolipoprotein E e2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry 2002;73:672-677.
26. Hypertension Detection and Follow-Up Program Cooperative Group: Race, education, and prevalence of hypertension. Am J Epidemiol 1977;106:351-361.
27. Morris MC, Scherr PA, Hebert LE, Bennett DA, Wilson RS, Glynn RJ, Evans DA: The cross-sectional association between blood pressure and Alzheimer's disease in a biracial community population of older persons. J Gerontol A Biol Sci Med Sci 2000;55:M130-M136.
28. Anonymous: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure 2004. NIH Publication No 04-5230.
29. Hixson J, Vernier DO: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990;31:545-548.
30. Wenham PR, Price WH, Blundell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
31. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 1972;74:187-220.
32. Laird N, Ware J: Random-effects models for longitudinal data. Biometrics 1982;38:963-973.
33. Wilson RS, Gilley DW, Bennett DA, Beckett LA, Evans DA: Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychol Aging 2000;15:18-28.
34. Qiu C, Winblad B, Fastbom J, Fratiglioni L: Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD. Neurology 2003;61:655-660.
35. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
36. Tsai MS, Tangalos EG, Petersen RC, Smith GE, Schaid DJ, Kokmen E, Ivnik RJ, Thibodeau SN: Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994;54:643-649.
37. Myers RH, Schaefer EJ, Wilson PW, D'Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA: Apolipoprotein E epsilon 4 association with dementia in a population-based study: The Framingham Study. Neurology 1996;46:673-677.
38. Hebert LE, Scherr PA, Bennett DA, Bienias JL, Wilson R, Morris MC, Evans DA: Blood pressure and change in cognitive function in late life: a biracial longitudinal population study. Neurology 2004;62:2021-2024.
39. Glynn RJ, Beckett LA, Hebert LE, Morris MC, Scherr PA, Evans DA: Current and remote blood pressure and cognitive decline. JAMA 1999;281:438-445.
40. Guo Z, Fratiglioni L, Windblad B, Viitanen M: Blood pressure and performance on the Mini-Mental State Examination in the very old: cross-sectional and longitudinal data from the Kungshomen Project. Am J Epidemiol 1997;145:1106-1113.
41. Tzourio C, Dufouil C, Ducimetiere P, Alperovitch A: Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. Neurology 1999;53:1948-1952.
42. Kochanek KD, Murphy SL, Anderson RN, Scott C: Deaths: final data for 2002, table 3. Natl Vital Stat Rep 2004;53:21.
43. Launer LJ, Masaki K, Petrovitch H, Foley D, Havalik RJ: The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA 1995;274:1846-1851.
44. Carmelli D, Swan GE, Reed T, Miller B, Wolf PA, Jarvik GP, Schellenberg GD: Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology 1998;50:1580-1585.
45. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR: Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993;138:353-364.
46. Elias MF, Robbins MA, Elias PK, Streeten DHP: A longitudinal study of blood pressure in relation to performance on the Wechsler Adult Intelligence Scale. Health Psychol 1998;17:486-493.
47. Kilander L, Nyman H, Boberg M, Lithell H: The association between low diastolic blood pressure in middle age and cognitive function in old age: a population-based study. Age Ageing 2000;29:243-248.
48. Swan GE, Carmelli D, Larue A: Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke 1998;29:2334-2340.
49. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.